image
Healthcare - Biotechnology - NASDAQ - US
$ 14.37
-0.76 %
$ 101 M
Market Cap
-0.6
P/E
BALANCE SHEET
67 M ASSETS
40.84%
75.2 M LIABILITIES
49.00%
-8.21 M EQUITY
-182.71%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Cidara Therapeutics, Inc.
image
Current Assets 60.9 M
Cash & Short-Term Investments 35.8 M
Receivables 16.2 M
Other Current Assets 8.83 M
Non-Current Assets 6.18 M
Long-Term Investments 0
PP&E 5.13 M
Other Non-Current Assets 1.05 M
Current Liabilities 67.4 M
Accounts Payable 3.77 M
Short-Term Debt 2.6 M
Other Current Liabilities 61 M
Non-Current Liabilities 7.82 M
Long-Term Debt 3.58 M
Other Non-Current Liabilities 4.24 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012
ASSETS
Cash & Cash Equivalents 35.8 32.7 62.3 35.9 60.3 74.6 75.3 104.6 107.5 22.8 0.2 1 K
Short Term Investments 0 0 0 0 0 0 14.5 19.3 45.0 0 0 0
Receivables 16.2 5.8 5.4 11.2 10 K 0 0.3 0 0 0 0 0
Inventory 6.1 1 (2.6) 0 (5.5) 0 (0.3) 0 0 0 0 0
Other Current Assets 2.7 13.1 6.7 10.1 15.5 2.6 2.0 1.6 1.4 0.2 13 K 0
Total Current Assets 60.9 45.1 71.7 57.2 65.8 77.1 77.7 105.4 108.2 23.0 0.2 1 K
PP&E 5.1 1.4 2.5 1.2 2.1 0.7 1.0 1.4 1.7 0.9 0 0
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 1.0 0.6 0.5 2.0 1.1 1.3 0.3 0.2 72 K 0.5 3 K 0
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 67.0 47.6 75.3 60.4 69.0 79.1 79.0 107.0 110.0 24.4 0.2 0
LIABILITIES
Accounts Payable 3.8 1.4 1.3 4.6 1.9 2.8 2.6 2.9 3.1 1.2 32 K 0
Short Term Debt 2.6 1.2 4.9 8.9 11.6 9.9 2.7 0 0 0 0 0
Other Current Liabilities 17.9 12.6 13.9 11.2 6.9 7.1 6.8 6.0 2.9 2.0 84 K 80 K
Total Current Liabilities 67.4 30.0 34.0 38.6 30.2 19.9 12.1 8.9 6.0 3.2 0.1 80 K
Long Term Debt 3.6 0 1.3 0 0.9 0 7.2 9.8 0 0 1.5 0
Deferred Tax Income 0 0.4 (1.3) 0 0 0 0 0 0 0 0 0
Other Liabilities 0 0 0 0 0 81 K 0 80 K 88 K 34 K 0 0
Total Liabilities 75.2 50.5 53.8 49.7 31.1 20.0 19.3 18.8 6.1 3.2 1.6 80 K
EQUITY
Common Stock 9 K 7 K 7 K 4 K 3 K 3 K 2 K 2 K 1 K 0 0 1 K
Retained Earnings (441.4) (407.0) (377.2) (334.7) (259.8) (218.7) (149.4) (93.7) (45.5) (13.3) (1.4) 66 K
Other Accumulative Comprehensive Income/Loss 0 0 0 0 0 0 8 K 1 K 8 K (0.2) 0 0
Total Equity (8.2) (2.9) 21.6 10.7 37.8 59.1 59.7 88.2 103.9 21.1 (1.4) 65 K
Total Liabilities and Equity 67.0 47.6 75.3 60.4 69.0 79.1 79.0 107.0 110.0 24.4 0.2 0
SHARES OUTSTANDING
Common Shares Outstanding 4.4 3.5 2.6 2.1 1.5 1.3 0.9 0.7 0.7 41 K 16.2 K 17.7 K